185 related articles for article (PubMed ID: 26361372)
21. Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity.
Fong KP; Pacheco CM; Otis LL; Baranwal S; Kieba IR; Harrison G; Hersh EV; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2006 Nov; 8(11):1753-67. PubMed ID: 16827908
[TBL] [Abstract][Full Text] [Related]
22. Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.
Walters MJ; Brown AC; Edrington TC; Baranwal S; Du Y; Lally ET; Boesze-Battaglia K
Mol Oral Microbiol; 2013 Oct; 28(5):342-53. PubMed ID: 23678967
[TBL] [Abstract][Full Text] [Related]
23. Transfection of non-susceptible cells with Ovis aries recombinant lymphocyte function-associated antigen 1 renders susceptibility to Mannheimia haemolytica leukotoxin.
Lawrence PK; Dassanayake RP; Knowles DP; Srikumaran S
Vet Microbiol; 2007 Nov; 125(1-2):91-9. PubMed ID: 17590539
[TBL] [Abstract][Full Text] [Related]
24. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells.
Dietmann A; Millonig A; Combes V; Couraud PO; Kachlany SC; Grau GE
Microb Pathog; 2013; 61-62():43-50. PubMed ID: 23665198
[TBL] [Abstract][Full Text] [Related]
25. Leukotoxin (LtxA/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes.
Prince DJ; Patel D; Kachlany SC
Sci Rep; 2021 Sep; 11(1):18086. PubMed ID: 34508147
[TBL] [Abstract][Full Text] [Related]
26. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
[TBL] [Abstract][Full Text] [Related]
27. Aggregatibacter actinomycetemcomitans induces detachment and death of human gingival epithelial cells and fibroblasts via elastase release following leukotoxin-dependent neutrophil lysis.
Hiyoshi T; Domon H; Maekawa T; Nagai K; Tamura H; Takahashi N; Yonezawa D; Miyoshi T; Yoshida A; Tabeta K; Terao Y
Microbiol Immunol; 2019 Mar; 63(3-4):100-110. PubMed ID: 30817027
[TBL] [Abstract][Full Text] [Related]
28. RTX toxins recognize a beta2 integrin on the surface of human target cells.
Lally ET; Kieba IR; Sato A; Green CL; Rosenbloom J; Korostoff J; Wang JF; Shenker BJ; Ortlepp S; Robinson MK; Billings PC
J Biol Chem; 1997 Nov; 272(48):30463-9. PubMed ID: 9374538
[TBL] [Abstract][Full Text] [Related]
29. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Gupta A; Le A; Belinka BA; Kachlany SC
Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
31. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
[TBL] [Abstract][Full Text] [Related]
32. Recombinant expression of bovine LFA-1 and characterization of its role as a receptor for Mannheimia haemolytica leukotoxin.
Dileepan T; Thumbikat P; Walcheck B; Kannan MS; Maheswaran SK
Microb Pathog; 2005; 38(5-6):249-57. PubMed ID: 15925274
[TBL] [Abstract][Full Text] [Related]
33. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.
Brown AC; Boesze-Battaglia K; Du Y; Stefano FP; Kieba IR; Epand RF; Kakalis L; Yeagle PL; Epand RM; Lally ET
Cell Microbiol; 2012 Jun; 14(6):869-81. PubMed ID: 22309134
[TBL] [Abstract][Full Text] [Related]
34. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
[TBL] [Abstract][Full Text] [Related]
35. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.
Fagerberg SK; Jakobsen MR; Skals M; Praetorius HA
Infect Immun; 2016 Nov; 84(11):3114-3130. PubMed ID: 27528275
[TBL] [Abstract][Full Text] [Related]
37. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
38. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
39. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
Crosby JA; Kachlany SC
Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
[TBL] [Abstract][Full Text] [Related]
40. HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA).
Hioe CE; Tuen M; Vasiliver-Shamis G; Alvarez Y; Prins KC; Banerjee S; Nádas A; Cho MW; Dustin ML; Kachlany SC
PLoS One; 2011; 6(8):e23202. PubMed ID: 21850260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
